FGFR alterations in pediatric cancers: Opportunity for targeted therapy

被引：0
|
作者：
LI, Ivan
Huo, Yuchen
Li, Gary
Zage, Peter
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A165
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK
    Lau, David K.
    Luk, Ian Y.
    Jenkins, Laura J.
    Martin, Andrew
    Williams, David S.
    Schoffer, Kael L.
    Chionh, Fiona
    Buchert, Michael
    Sjoquist, Katrin
    Boussioutas, Alex
    Hayes, Sarah A.
    Ernst, Matthias
    Weickhardt, Andrew J.
    Pavlakis, Nick
    Tebbutt, Niall C.
    Mariadason, John M.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (04) : 704 - 715
  • [42] Ibrutinib: A New Targeted Therapy for Hematologic Cancers
    Smithson, Caroline R.
    Schneider, Susan M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (03) : E47 - E51
  • [43] Targeted therapy in rare cancers—adopting the orphans
    Javier Munoz
    Razelle Kurzrock
    Nature Reviews Clinical Oncology, 2012, 9 : 631 - 642
  • [44] Targeted therapy in head/neck and gastric cancers
    Chung-Tsen Hsueh
    Journal of Hematology & Oncology, 5 (Suppl 1)
  • [45] Molecular targeted cancer therapy for childhood cancers
    Fulda, S.
    ONKOLOGE, 2011, 17 (11): : 1045 - +
  • [46] New developments in targeted therapy for thyroid cancers
    Pfister, David G.
    CANCER INVESTIGATION, 2007, 25 : 67 - 68
  • [47] The Opportunity for Occupational Therapy in Pediatric Disaster Recovery
    Rashad, Diamond E.
    Zapf, Susan A.
    Groger, Sandra E.
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2022, 76 (04):
  • [48] Downregulation of FGFR3 illustrates the potential of FGFR3 targeted therapy in bladder cancer
    Tomlinson, Darren C.
    Hurst, Carolyn
    Pitt, Eva
    Knowles, Magaret
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy
    Wang, Zechen
    Muthusamy, Viswanathan
    Petrylak, Daniel P.
    Anderson, Karen S.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [50] Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy
    Zechen Wang
    Viswanathan Muthusamy
    Daniel P. Petrylak
    Karen S. Anderson
    npj Precision Oncology, 7
12345